Radius Health
950 Winter Street
Waltham
Massachusetts
02451
United States
Tel: 617-551-4000
Fax: 617-551-4701
Website: http://www.radiuspharm.com/
Email: info@radiuspharm.com
About Radius Health
Radius is a science-driven biopharmaceutical company focused on developing new therapeutics for patients with osteoporosis as well as other serious endocrine-mediated diseases.Radius is committed to the research and development of new therapeutics for the large and underserved osteoporosis market.
YEAR FOUNDED:
October 3, 2003
LEADERSHIP:
Founders: John Katzenellenbogen, Stavros C. Manolagas, Michael Rosenblatt and John T. Potts
CEO: Robert Ward
CMO (Medical): Lorraine Fitzpatrick
CFO: Nick Harvey
CSO (Scientific): Gary Hattersley
JOBS:
Please click here for Radius Health job opportunities.
CLINICAL TRIAL:
Please click here for clinical trial information.
231 articles with Radius Health
-
Radius Selects First Preclinical Candidate From SARM Discovery Program for the Treatment of Muscle Loss and Other Musculoskeletal Conditions
6/9/2008
-
Radius Completes Enrollment of Phase II Clinical Trial of BA058 for Osteoporosis; Milestone triggers $28.3M Second-tranche Investment
4/2/2008
-
Karo Bio AB Reacquires Rights to SARM Compounds from Radius
2/28/2008
-
Radius Announces Launch of RAD1901 Clinical Program for the Treatment of Hot Flashes
1/30/2008
-
Radius Raises $57.5 Million in Second Private Financing Round
4/2/2007
-
Radius Appoints Nick Harvey Senior Vice President And Chief Financial Officer
1/2/2007
-
Radius And Karo Bio AB Announce Licensing Agreement For Novel SARM Compounds
9/12/2006
-
Radius Licenses Worldwide Exclusive Rights To Estrogen Receptor-Beta Agonists
8/7/2006
-
Radius Announces Licensing Agreement To Develop And Commercialize Eisai Company, Ltd. SERMs
6/29/2006
-
Radius Appoints Louis O'Dea Senior Vice President And Chief Medical Officer
4/12/2006
-
Radius Announces Licensing Agreement For Ipsen Osteoporosis Proprietary Molecule BA058
12/13/2005